new glp 1 meds List of approved and pending GLP-1 medications Swiss Re says GLP-1 drugs
Description
Archived from the original on 9 July 2025
Forest plot of Exenatide versus comparators on the risk of overall Respiratory diseases
Across phase III trials of GLP-1 receptor agonist and multi-hormone receptor modulator obesity drugs in adults with overweight or obesity, the magnitude of blood pressure-lowering was closely associated with the degree of weight loss, highlighting the clinically relevant yet often underappreciated blood pressure-lowering potential of these drugs, the authors concluded
Oral and injectable semaglutide have broadly comparable gastrointestinal risk, high rates of mostly mild gastrointestinal symptoms, and low rates of serious events, Dr
However, doctors can still choose to prescribe these medications off-label for weight loss use
K., Gurbuz, S., & Haupt, A
